| Literature DB >> 34991555 |
Alessandro Ghiani1, Konstantinos Tsitouras2, Joanna Paderewska2, Dieter Munker3, Swenja Walcher2, Claus Neurohr2,4, Nikolaus Kneidinger3,4.
Abstract
BACKGROUND: Various complications may arise from prolonged mechanical ventilation, but the risk of tracheal stenosis occurring late after translaryngeal intubation or tracheostomy is less common. This study aimed to determine the prevalence, type, risk factors, and management of tracheal stenoses in mechanically ventilated tracheotomized patients deemed ready for decannulation following prolonged weaning.Entities:
Keywords: Mechanical ventilation; Tracheostomy; Ventilator weaning
Mesh:
Year: 2022 PMID: 34991555 PMCID: PMC8740413 DOI: 10.1186/s12890-022-01821-6
Source DB: PubMed Journal: BMC Pulm Med ISSN: 1471-2466 Impact factor: 3.317
Fig. 1Patient flow diagram
Clinical characteristics on admission to the weaning center—comparison of patients with and without tracheal stenosis
| Clinical characteristics | All patients (n = 357) | Tracheal stenosis (n = 114) | No tracheal stenosis (n = 243) | |
|---|---|---|---|---|
| Age (years) | 69 (60–75) | 69 (61–75) | 69 (59–76) | 0.415b |
| Male gender | 216 (60.5) | 66 (57.9) | 150 (61.7) | 0.490c |
| Body mass index (kg/m2) | 26.2 (± 9.1) | 27.3 (± 9.3) | 25.7 (± 9.0) | |
| Obesity (defined as BMI ≥ 30 kg/m2) | 93 (26.1) | 40 (35.1) | 53 (21.8) | |
| Smoking history | 172 (48.2) | 54 (47.4) | 118 (48.6) | 0.834c |
| APACHE-II (points) | 16 (13–19) | 15 (13–19) | 16 (13–20) | 0.449b |
| Albumin (g/dL) | 2.2 (± 0.5) | 2.3 (± 0.5) | 2.2 (± 0.5) | |
| Pre-existing HMV-NIV | 17 (6.0) | 5 (4.4) | 12 (4.9) | 0.820c |
| Ventilator days on admission | 22 (15–31) | 22 (15–30) | 23 (15–33) | 0.947b |
| Percutaneous tracheostomy | 272 (76.2) | 94 (82.5) | 178 (73.3) | 0.057c |
| Intubation to tracheostomy (days) | 10 (6–14) | 10 (6–14) | 10 (6–15) | 0.910b |
| ECLA | 29 (8.1) | 9 (7.9) | 20 (8.2) | 0.914c |
| Pneumonia | 118 (33.1) | 37 (32.5) | 81 (33.3) | 0.870c |
| Surgery | 84 (23.5) | 22 (19.3) | 62 (25.5) | 0.197c |
| Acute exacerbation of COPD | 38 (10.6) | 13 (11.4) | 25 (10.3) | 0.750c |
| Sepsis (including septic shock) | 35 (9.8) | 12 (10.5) | 23 (9.5) | 0.754c |
| Cardiopulmonary resuscitation | 28 (7.8) | 11 (9.6) | 17 (7.0) | 0.385c |
| Acute heart failure | 11 (3.1) | 3 (2.6) | 8 (3.3) | 0.737c |
| Other | 43 (12.0) | 16 (14.0) | 27 (11.1) | 0.429c |
| Charlson comorbidity index (points) | 5 (4–7) | 5 (4–7) | 5 (4–7) | 0.997b |
| Diabetes mellitus | 108 (30.3) | 42 (36.8) | 66 (27.2) | 0.064c |
| Coronary artery disease | 104 (29.1) | 32 (28.1) | 72 (29.6) | 0.763c |
| Renal insufficiency | 93 (26.1) | 30 (26.3) | 63 (25.9) | 0.938c |
| Hemodialysis | 43 (12.0) | 15 (13.1) | 28 (11.5) | 0.432c |
| COPD | 95 (26.6) | 33 (28.9) | 62 (25.5) | 0.494c |
| Immunosuppression§ | 65 (18.2) | 16 (14.0) | 49 (20.2) | 0.162c |
| Steroids* | 36 (10.1) | 8 (7.0) | 28 (11.5) | 0.188c |
| Chronic heart failure | 59 (16.5) | 15 (13.2) | 44 (18.1) | 0.241c |
| Malignancy | 37 (10.4) | 9 (7.9) | 28 (11.5) | 0.295c |
| Hepatopathy | 24 (6.7) | 6 (5.3) | 18 (7.4) | 0.451c |
| Interstitial lung disease | 25 (7.0) | 4 (3.5) | 21 (8.6) | 0.077c |
| Neuromuscular disease | 4 (1.1) | 0 (0.0) | 4 (1.6) | 0.169c |
The bold values represent statistically significant results (with P < 0.05)
Continuous variables are presented as mean (± standard deviation) or median (– interquartile range [IQR]); categorical variables are presented as numbers (%)
BMI, body mass index; APACHE-II, Acute Physiology and Chronic Health Evaluation II score; HMV-NIV, home mechanical ventilation-non-invasive ventilation; ECLA, extracorporeal lung assistance (in acute respiratory failure); COPD, chronic obstructive pulmonary disease
*Refers to more than 20 mg of prednisolone for more than 2 weeks throughout weaning
§These include 36 patients on steroids, 21 patients with chemotherapy within the last three months, six after organ transplant, one with HIV stage C, and one with splenectomy
aP value for differences between patients with and without subglottic tracheal stenosis
bMann-Whitney U test
cChi-squared test
Characteristics and management of tracheal stenosis
| Characteristics | Patients with tracheal stenosis (n = 114) |
|---|---|
| Localized granulation tissue formation | 109 (95.6) |
| Concentric granulation tissue formation | 5 (4.4) |
| Concentric scar stenosis | 0 (0.0) |
| Fibrous web-like stenosis | 0 (0.0) |
| Upper tracheal stenosis | 100 (87.7) |
| Subglottic stenosis | 14 (12.3) |
| Mid/lower tracheal stenosis | 0 (0.0) |
| % of lumen occlusion | |
| All patients | 40 (25–50) |
| Patients referred to bronchoscopy | 50 (40–60) |
| Patients with subglottic stenosis | 60 (50–70) |
| Myer-Cotton Grading | |
| Grade 1 (< 50%) | 66 (57.9) |
| Grade 2 (50–69%) | 33 (28.9) |
| Grade 3 (70–99%) | 13 (11.4) |
| Grade 4 (100%) | 2 (1.8) |
| Tracheal cartilage ring fracture | 24 (21.1) |
| Cannulation duration (days) | 37 (27–50) |
| No. of patients referred to bronchoscopy | 77 |
| No. of endoscopic procedures | 105 |
| ≥ 1 procedure | 77 (80.2) |
| ≥ 2 procedures | 21 (21.9) |
| = 3 procedures | 7 (7.3) |
| Nd:YAG Laser | 98 (93.3) |
| Argon plasma coagulation | 4 (3.8) |
| Forceps resection | 3 (2.9) |
| Mechanical dilatation | 0 (0.0) |
| % of lumen occlusion post-intervention | 10 (0–20) |
| Myer-Cotton Grading post-intervention | |
| Grade 1 (< 50%) | 76 (98.7) |
| Grade 2 (50–69%) | 1 (1.3) |
| Grade 3 (70–99%) | 0 (0.0) |
| Grade 4 (100%) | 0 (0.0) |
| Laryngotracheal surgery | 3 (2.6) |
Continuous variables are presented as median (– interquartile range [IQR]); categorical variables are presented as number or number (%)
No./no., number
Fig. 2Variables associated with tracheal stenosis—results of binary logistic regression analysis. Forest plot of variables included in the univariable and multivariable (red dots) regression analysis. Odds ratios were reported with 95% confidence intervals